RecallRadar

FDA Drug recall D-787-2013

Trimix, compounded by Olympia Pharmacy, Orlando, FL

On 2013-07-17 the FDA classified a Class II recall of Trimix, compounded by Olympia Pharmacy, Orlando, FL by Lowlite Investments, citing lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-787-2013
ClassificationClass II
Statusongoing
Initiated2013-05-29
Published2013-07-17
Last updated2026-09-13 11:51 UTC
CompanyLowlite Investments
DistributionUS

Product

Trimix, compounded by Olympia Pharmacy, Orlando, FL

Reason

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Identifiers

code_info
B5015 Exp 8/15/13, C50001 Exp 8/28/13, B5011 Exp 8/1/13, C42215 Exp 6/22/13, A5028 Exp 6/2/13, B5011 Exp 6/1/13, B5020…B5015 Exp 8/15/13, C50001 Exp 8/28/13, B5011 Exp 8/1/13, C42215 Exp 6/22/13, A5028 Exp 6/2/13, B5011 Exp 6/1/13, B5020 Exp 6/1/13, B50112 Exp 8/11/13, C4186 Exp 6/18/13, C4158 Exp 6/15/13, C4149 Exp 6/14/13, C4111 Exp 6/11/13, B4124 Exp 8/12/13, B4154 Exp 8/15/13, B4198 Exp 8/19/13, B4226 Exp 8/22/13, B4268 Exp 8/22/13, C40522 Exp 9/5/13, C4118 Exp 9/1/13, C4711 Exp 9/7/13, C41121 Exp 9/11/13, C4126 Exp 9/12/13 and B42715 Exp 8/27/13.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-787-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.